Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

BACKGROUND: The association between early changes in albuminuria and kidney and cardiovascular events is primarily based on trials of renin-angiotensin system blockade. It is unclear whether this association occurs with sodium-glucose cotransporter 2 inhibition. METHODS: The Canagliflozin and Renal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Soc Nephrol
Autors principals: Oshima, Megumi, Neuen, Brendon L., Li, JingWei, Perkovic, Vlado, Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Mahaffey, Kenneth W., De Nicola, Luca, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Jardine, Meg J., Heerspink, Hiddo J.L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7790219/
https://ncbi.nlm.nih.gov/pubmed/32998938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2020050723
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars